Loading clinical trials...
Loading clinical trials...
DSUVIA Early Evaluation of PAIN (DEEP) Trial
Randomized, interventional trial of Emergency Department (ED) administration of DSUVIA (sufentanil) versus standard care pain management comparing pain treatment outcomes in injured patients with moderate to severe pain
Age
18 - 70 years
Sex
ALL
Healthy Volunteers
No
University of Pittsburgh
Pittsburgh, Pennsylvania, United States
Start Date
August 5, 2022
Primary Completion Date
January 21, 2024
Completion Date
January 21, 2024
Last Updated
April 30, 2025
150
ACTUAL participants
Sufentanil 30 MCG Sublingual Tablet
DRUG
standard care pain treatment
DRUG
Lead Sponsor
Frank Guyette
Collaborators
NCT06366282
NCT05568888
NCT03101982
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions